Two Sigma Investments »

Eliem Therapeutics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $227k 113k 2.01
2025-06-30 $223k 180k 1.24
2025-03-31 $311k 255k 1.22
2024-12-31 $428k 238k 1.80
2024-09-30 $120k 24k 5.09

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core S&p500 Etf (IVV)
Rivian Automotive Com Cl A (RIVN)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Micron Technology (MU)
Lockheed Martin Corporation (LMT)
Ishares Tr Rus 1000 Grw Etf (IWF)
Microsoft Corporation (MSFT)
Alnylam Pharmaceuticals (ALNY)

View all positions for Two Sigma Investments

Top funds holding Eliem Therapeutics

RA Capital Management
MPM Oncology Impact Management
ADAR1 Capital Management
Vanguard Group
Affinity Asset Advisors
Kynam Capital Management
Dr. Jeffrey R. Jay, M.D.
Sphera Funds Management
Point72 Asset Management
Peapod Lane Capital
Millennium Management
Nan Fung Trinity
Susquehanna International
BlackRock
Renaissance Technologies

View all funds holding Eliem Therapeutics